Barclays’s Cyclerion Therapeutics CYCN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-2,302
| Closed | -$7K | – | 3337 |
|
|
2021
Q3 | $7K | Sell |
2,302
-2,115
| -48% | -$6.43K | ﹤0.01% | 3792 |
|
|
2021
Q2 | $17K | Sell |
4,417
-14,099
| -76% | -$54.3K | ﹤0.01% | 3753 |
|
|
2021
Q1 | $52K | Buy |
18,516
+11,367
| +159% | +$31.9K | ﹤0.01% | 3517 |
|
|
2020
Q4 | $22K | Sell |
7,149
-3,021
| -30% | -$9.3K | ﹤0.01% | 3368 |
|
|
2020
Q3 | $62K | Sell |
10,170
-3,013
| -23% | -$18.4K | ﹤0.01% | 3200 |
|
|
2020
Q2 | $77K | Buy |
13,183
+5,354
| +68% | +$31.3K | ﹤0.01% | 3222 |
|
|
2020
Q1 | $20K | Sell |
7,829
-15,788
| -67% | -$40.3K | ﹤0.01% | 3381 |
|
|
2019
Q4 | $64K | Buy |
23,617
+11,827
| +100% | +$32.1K | ﹤0.01% | 3544 |
|
|
2019
Q3 | $143K | Sell |
11,790
-3,433
| -23% | -$41.6K | ﹤0.01% | 3207 |
|
|
2019
Q2 | $174K | Buy |
+15,223
| New | +$174K | ﹤0.01% | 3283 |
|